The use of platelet-rich plasma in treatment of olfactory dysfunction: A pilot study.
Carol H Yan, David C Mundy, Zara M Patel
https://pubmed.ncbi.nlm.nih.gov/32337347/Actively Recruiting
Led by Taipei Veterans General Hospital, Taiwan · Updated on 2026-10-05
60
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are investigating two different ways to deliver autologous platelet-rich plasma PRP to improve smell function in adults who have had persistent olfactory dysfunction for more than three months. This trial focuses on comparing carrier-assisted topical application versus intranasal injection of PRP to see which method better restores the sense of smell and which is more comfortable with fewer side effects. The study includes adults aged 18 to 80 with confirmed olfactory loss despite previous olfactory training. Participants will receive a single PRP treatment prepared on-site using a standardized process. One group will have PRP injected directly into the olfactory cleft mucosa under local anesthesia with endoscopic guidance, while the other group will have PRP applied topically via a PRP-soaked bioabsorbable carrier placed inside the olfactory cleft. After treatment, all participants will continue daily olfactory training for 12 weeks. Follow-up visits will occur at 2 weeks, 1 month, and 3 months to monitor progress. During the study, participants will undergo smell testing using the Sniffin Sticks test at baseline and up to 3 months post-treatment, with possible extension to 6 and 12 months. They will also complete quality-of-life questionnaires and assessments related to olfactory function and mood. Researchers will evaluate changes in smell scores, patient-reported outcomes, procedure tolerability, and any adverse effects. This information will help determine the best method for delivering PRP to support olfactory rehabilitation.
CONDITIONS
Topical Versus Injection PRP for Olfactory Dysfunction
D
Dr. Yun-Ting Chao Principal Investigator (Attending Physician and Head of Dep.), PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Taipei Veterans General Hospital, Taiwan
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single session plus 12 weeks of training
Participants receive a single PRP treatment either by injection into the olfactory cleft or by application of a PRP-soaked carrier placed in the olfactory cleft under local anesthesia. Daily olfactory training continues for 12 weeks after treatment.
Follow-up visits at 2 weeks, 1 month, and 3 months post-treatment
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Carol H Yan, David C Mundy, Zara M Patel
https://pubmed.ncbi.nlm.nih.gov/32337347/Alexander Duffy, Bita Naimi, Emily Garvey...
https://pubmed.ncbi.nlm.nih.gov/38722276/Rong-San Jiang, Yi-Fang Chiang
https://pubmed.ncbi.nlm.nih.gov/39404838/Jerome R Lechien, Serge D Le Bon, Sven Saussez
https://pubmed.ncbi.nlm.nih.gov/36520209/Ah Young Bae, Do Hyun Kim, Se Hwan Hwang
https://pubmed.ncbi.nlm.nih.gov/39664044/Taipei Veterans General Hospital, Taiwan
Lead Sponsor